SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom shares faced volatility as investors weighed a strong quarterly performance and ambitious multi-year AI revenue forecasts against a fourth-quarter revenue outlook that slightly missed high-end expectations. While some in the community expressed frustration over price movement and market sentiment, many traders highlighted the company's long-term AI infrastructure growth potential as a significant buying opportunity.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investors focus on the upcoming Cybercab robotaxi launch, with sentiment divided between enthusiasm for the event and skepticism regarding the company's valuation and delivery targets. Traders are actively debating whether the event will trigger a "buy the hype, sell the news" scenario or a potential short squeeze.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake shares surged following better-than-expected quarterly financial results and an upward revision to its full-year guidance, with investors highlighting accelerating product revenue and increased demand for its AI-driven platform. While many traders celebrated the strong beat, some market participants remain skeptical, citing concerns over the company's premium valuation and lack of GAAP profitability.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is trending following its third-quarter earnings report, where the company exceeded expectations and raised its full-year guidance, though shares experienced volatility as traders weighed these strong results against management's comments on supply chain constraints and margin outlook. Investors are divided, with many bullish on the company's expanding AI infrastructure and networking deal with Oracle, while others remain skeptical due to the stock's muted reaction and broader concerns regarding AI hardware spending.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx shares are seeing heavy volatility following the failure of late-stage trials for its experimental Angelman syndrome therapy, which led to multiple analyst downgrades and price target cuts. While the clinical setback has dampened near-term growth expectations, some investors are highlighting the company's existing commercial revenue streams and upcoming PDUFA catalysts as potential floor support.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is receiving attention as analysts raise price targets and initiate coverage with bullish ratings, citing the firm's growth in prediction markets, its blockchain network, and strong net deposit inflows. While some users express frustration over price suppression and algorithmic trading, broader community sentiment remains focused on the company's expansion beyond its core brokerage business.

Victoria's Secret & Co. operates as a lingerie, clothing and beauty retailer. It offers bras, panties, lingerie, sleepwear, apparel, sport and swim apparel, and beauty products. The company was founded in 1963 and is headquartered in Reynoldsburg, OH.

Victoria`s Secret & Co

Victoria's Secret is trending following a strong quarterly earnings report that beat revenue and earnings expectations, accompanied by an upward revision to full-year guidance. While some traders express optimism regarding the company's turnaround efforts and brand momentum, others remain skeptical, citing long-term demographic challenges and historical volatility.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

The semiconductor sector is experiencing high volatility as traders react to Nvidia's strong earnings alongside weakness in memory chip stocks. Market participants remain split, with some viewing the sector as a long-term AI-driven opportunity, while others express caution regarding potential bubbles, geopolitical risks, and broader economic headwinds.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is trending as investors react to the company's fiscal third-quarter earnings, which featured a revenue and earnings beat alongside raised fiscal year guidance. While some traders noted a sharp pullback following the report, the broader conversation centers on the company's role as a key infrastructure provider amid sustained AI-driven demand for high-speed optical networking.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as traders speculate on a potential buyout, fueled by reports of interest from larger biopharma companies despite a lack of formal confirmation. While some investors view the stock's recent price volatility as a sign of institutional accumulation and imminent deal-making, others are focused on the company's fundamental growth trajectory and upcoming data readouts for its subcutaneous treatment formulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Exencial Industry Tidings - 28-04-2026 and more

In this briefing: Exencial Industry Tidings - 28-04-2026 Vedanta's F&O Reset: What Happens to Your Contracts When One Company Becomes Five India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 India Steel Industry: Should We Expect a Turnaround from Q4FY26? 1. Exencial Industry Tidings - 28-04-2026 India keeps dairy sector out of tariff concessions under any of its FTAs Wheat procurement drive poses several challenges for agencies in Punjab Jayaswal Neco Inds.' sales up by 17.8% in March 2026 quarter 2. Vedanta's F&O Reset: What Happens to Your Contracts When One Company Becomes Five All active Vedanta F&O contracts expire compulsorily on April 29, 2026. Fresh contracts on the restructured Vedanta Ltd resume April 30 at 10:00 AM IST. The four demerged entities have no derivatives access for at least six months post-listing. Open interest holders face forced settlement and mark-to-market crystallisation at a structurally adjusted price. 3.

Brief India: Vedanta's F&O Reset: What Happens to Your Contracts When One Company Becomes Five and more

In this briefing: Vedanta's F&O Reset: What Happens to Your Contracts When One Company Becomes Five India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 India Steel Industry: Should We Expect a Turnaround from Q4FY26? HSIE Results Daily: Axis Bank, RBL Bank 1. Vedanta's F&O Reset: What Happens to Your Contracts When One Company Becomes Five All active Vedanta F&O contracts expire compulsorily on April 29, 2026. Fresh contracts on the restructured Vedanta Ltd resume April 30 at 10:00 AM IST. The four demerged entities have no derivatives access for at least six months post-listing. Open interest holders face forced settlement and mark-to-market crystallisation at a structurally adjusted price. 2. India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector India's flex workspace leasing surged 77% YoY in Q1 2026, with enterprises now driving 72% of absorption, a structural shift from the sector's startup origins All four listed operators (Awfis, Smartworks, WeWork India, IndiQube) report ~84% occupancy with weighted average client tenures of 32-42 months, signalling durable revenue visibility.

Brief India: India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector and more

In this briefing: India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 India Steel Industry: Should We Expect a Turnaround from Q4FY26? HSIE Results Daily: Axis Bank, RBL Bank Federal Bank: Priced to Perfection, Downgrade to ADD 1. India Flexible Workspace Sector: Enterprise Demand Is Repricing the Sector India's flex workspace leasing surged 77% YoY in Q1 2026, with enterprises now driving 72% of absorption, a structural shift from the sector's startup origins All four listed operators (Awfis, Smartworks, WeWork India, IndiQube) report ~84% occupancy with weighted average client tenures of 32-42 months, signalling durable revenue visibility. GCC expansion is the sector's most powerful demand catalyst, with GCC flex portfolio share expected to more than double to 48% within two years. 2. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds.

Brief Consumer: J Front (3086 JP) Vs Ajinomoto (2802 JP): Two-Sigma Reversal Triggers Pair Trade Flip and more

In this briefing: J Front (3086 JP) Vs Ajinomoto (2802 JP): Two-Sigma Reversal Triggers Pair Trade Flip Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Aequitas: Seres Group A/H Lockup Expiry - US$500m Lockup Release, but All Are Underwater Result Update:CIE Automotive El Nino is Coming! - What it Means for Commodity Prices in 2026 1. J Front (3086 JP) Vs Ajinomoto (2802 JP): Two-Sigma Reversal Triggers Pair Trade Flip Context: The Ajinomoto (2802 JP) vs. J Front Retailing (3086 JP) price ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity. Highlight: Going long J Front Retailing (3086 JP) and short Ajinomoto (2802 JP) targets a 9% return. Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play. 2. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds.

Brief Equities Bottom-Up: Primer: First Bank Of Toyama (7184 JP) - Apr 2026 and more

In this briefing: Primer: First Bank Of Toyama (7184 JP) - Apr 2026 Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Primer: Minami Nippon Bank (8554 JP) - Apr 2026 Anritsu Corp (6754 JP): Full-year FY03/26 flash update PROP: Free Cash Flow Earmarked for Debt Reduction 1. Primer: First Bank Of Toyama (7184 JP) - Apr 2026 First Bank of Toyama is demonstrating an exceptional growth trajectory, with 3-year compound annual growth rates (CAGRs) for net income and EPS at 56.5% and 58.6%, respectively, significantly outpacing industry norms. As a regional bank, its fortunes are intrinsically linked to the economic vitality of the Toyama Prefecture. This geographic concentration presents both an opportunity for deep market penetration and a risk of exposure to localized economic downturns. The bank is well-positioned to benefit from Japan's shifting monetary policy. An end to the negative interest rate environment could significantly improve net interest margins, a key driver of profitability for the banking sector.

Brief Consumer: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 and more

In this briefing: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Aequitas: Seres Group A/H Lockup Expiry - US$500m Lockup Release, but All Are Underwater Result Update:CIE Automotive El Nino is Coming! - What it Means for Commodity Prices in 2026 Great Wall Motor (2333 HK/601633 CH) - New-Model Sales as Key After 1Q26 Solid GPM 1. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds. Favorable Industry Tailwinds: The Indian seed market is poised for significant growth, driven by increasing demand for high-yielding seeds, government initiatives promoting agricultural productivity, and a structural shift towards climate-resilient agriculture. Attractive Valuation with Underlying Risks: The company trades at a significant discount to peers like Kaveri Seed.

Brief Equities Bottom-Up: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 and more

In this briefing: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Primer: Minami Nippon Bank (8554 JP) - Apr 2026 Anritsu Corp (6754 JP): Full-year FY03/26 flash update PROP: Free Cash Flow Earmarked for Debt Reduction Quam Morning Note (28 Apr) - Wuxi AppTec 1. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds. Favorable Industry Tailwinds: The Indian seed market is poised for significant growth, driven by increasing demand for high-yielding seeds, government initiatives promoting agricultural productivity, and a structural shift towards climate-resilient agriculture. Attractive Valuation with Underlying Risks: The company trades at a significant discount to peers like Kaveri Seed.

Brief Growth Ideas: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 and more

In this briefing: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Primer: Minami Nippon Bank (8554 JP) - Apr 2026 Impact Therapeutics (英派药业) Pre-IPO: Thoughts on Valuation Oil futures: Crude extends gains as US-Iran talks put on hold IPO Rating: Avalyn Pharma Inc. 1. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds. Favorable Industry Tailwinds: The Indian seed market is poised for significant growth, driven by increasing demand for high-yielding seeds, government initiatives promoting agricultural productivity, and a structural shift towards climate-resilient agriculture. Attractive Valuation with Underlying Risks: The company trades at a significant discount to peers like Kaveri Seed.

Brief India: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 and more

In this briefing: Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 India Steel Industry: Should We Expect a Turnaround from Q4FY26? HSIE Results Daily: Axis Bank, RBL Bank Federal Bank: Priced to Perfection, Downgrade to ADD Sun Pharmaceutical Industries: Organon M&A Provides Scale, Growth Revival Key. 1. Primer: Nath Bio Genes India (NBGL IN) - Apr 2026 Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds. Favorable Industry Tailwinds: The Indian seed market is poised for significant growth, driven by increasing demand for high-yielding seeds, government initiatives promoting agricultural productivity, and a structural shift towards climate-resilient agriculture. Attractive Valuation with Underlying Risks: The company trades at a significant discount to peers like Kaveri Seed.

Smartkarma | Primer: Nath Bio Genes India (NBGL IN) - Apr 2026

» Smartkarma / by αSK / Equity Bottom-Up Established Player with Strong R&D Focus: Nath Bio-Genes is a veteran in the Indian seed industry with over four decades of experience, a diversified product portfolio across field and vegetable crops, and a strong emphasis on research and development to produce high-quality, climate-resilient hybrid seeds. Favorable Industry Tailwinds: The Indian seed market is poised for significant growth, driven by increasing demand for high-yielding seeds, government initiatives promoting agricultural productivity, and a structural shift towards climate-resilient agriculture. Attractive Valuation with Underlying Risks: The company trades at a significant discount to peers like Kaveri Seed. However, this is set against a backdrop of flat recent financial performance, profitability concerns, and low liquidity, which warrant a cautious outlook. This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Nath Bio-Genes (India) Ltd. engages in the production and marketing of seeds. The firm offers categories of seeds including oil seeds & fiber, forage, fruits, field crop, vegetables and plant nutrition. It operates through the Agriculture Activities and Trading Activities segments. The company was founded on July 14, 1993 and is headquartered in Mumbai, India.

Current Price	153.06
Prev Close	152.30
Open	152.54
Dividend Yield	0.00%
50-Day Moving Average	160.09
Beta	N/A
Avg. Volume	17,790.52
PE Ratio	7.80

52-Week High	204.00
52-Week Low	126.15
Market Capitalization	2.91B
EPS (Annual)	20.98
Price to Book	0.43
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info